The deubiquitinating enzyme USP19 facilitates hepatocellular carcinoma progression through stabilizing YAP
- 11 October 2023
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 577, 216439
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- The Hippo Pathway: Biology and PathophysiologyAnnual Review of Biochemistry, 2019
- Risk factors and prevention of hepatocellular carcinoma in the era of precision medicineJournal of Hepatology, 2018
- Deubiquitinating enzymes in skeletal muscle atrophy—An essential role for USP19The International Journal of Biochemistry & Cell Biology, 2016
- YAP/TAZ at the Roots of CancerCancer Cell, 2016
- The BECN1-USP19 axis plays a role in the crosstalk between autophagy and antiviral immune responsesAutophagy, 2016
- Deubiquitylating enzyme USP9x regulates hippo pathway activity by controlling angiomotin protein turnoverCell Discovery, 2016
- USP19 modulates autophagy and antiviral immune responses by deubiquitinating Beclin‐1The EMBO Journal, 2016
- Mechanisms of Hippo pathway regulationGenes & Development, 2016
- Characterization of the Deubiquitinating Activity of USP19 and Its Role in Endoplasmic Reticulum-associated DegradationJournal of Biological Chemistry, 2014
- The Hippo pathway and human cancerNature Reviews Cancer, 2013